Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder
Chen HW, Bercik RS, Werner EF, Thung SF. Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder. Journal Of Urology 2011, 187: 178-184. PMID: 22100006, DOI: 10.1016/j.juro.2011.09.052.Peer-Reviewed Original ResearchConceptsPercutaneous tibial nerve stimulationTibial nerve stimulationQuality of lifeExtended release tolterodineIncremental cost-effectiveness ratioNerve stimulationTolterodine EROveractive bladderCost-effectiveness ratioSide effectsUrinary incontinencePercutaneous tibial nerve stimulation therapyTherapy side effectsSignificant side effectsCost-effectiveness modelMaintenance therapyImproved continencePrimary outcomeClinical circumstancesStimulation therapyMedical costsReduced qualityTherapy terminationBladderSocietal perspective